Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenwu Capsule in Amnestic Mild Cognitive Impairment
NCT01451749Phase 3Completed
- Sponsor
- North China Pharmaceutical
- Start
- Sep 2008
- Primary completion
- May 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Shenwu Capsule in amnestic mild cognitive impairment (MCI), sponsored by North China Pharmaceutical. Started Sep 2008; status: completed.
02
Drugs
Shenwu Capsule
03
Conditions
amnestic mild cognitive impairment (MCI)
Beyond the preview
Go deeper on NCT01451749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01451749.